These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Interaction of the DRD3 and BDNF gene variants in subtyped bipolar disorder. Lee SY, Chen SL, Chen SH, Chu CH, Chang YH, Lin SH, Huang SY, Tzeng NS, Kuo PH, Lee IH, Yeh TL, Yang YK, Lu RB. Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec 03; 39(2):382-7. PubMed ID: 22877924 [Abstract] [Full Text] [Related]
3. COMT and BDNF interacted in bipolar II disorder not comorbid with anxiety disorder. Lee SY, Chen SL, Wang YS, Chang YH, Huang SY, Tzeng NS, Lee IH, Yeh TL, Yang YK, Lu RB. Behav Brain Res; 2013 Jan 15; 237():243-8. PubMed ID: 23026378 [Abstract] [Full Text] [Related]
8. Dopamine D3 receptor Ser9Gly and catechol-o-methyltransferase Val158Met polymorphisms and acute pain in sickle cell disease. Jhun E, He Y, Yao Y, Molokie RE, Wilkie DJ, Wang ZJ. Anesth Analg; 2014 Nov 15; 119(5):1201-7. PubMed ID: 25102390 [Abstract] [Full Text] [Related]
9. Reduced dopamine receptor sensitivity as an intermediate phenotype in alcohol dependence and the role of the COMT Val158Met and DRD2 Taq1A genotypes. Schellekens AF, Franke B, Ellenbroek B, Cools A, de Jong CA, Buitelaar JK, Verkes RJ. Arch Gen Psychiatry; 2012 Apr 15; 69(4):339-48. PubMed ID: 22474103 [Abstract] [Full Text] [Related]
10. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study. Sáiz PA, García-Portilla MP, Arango C, Morales B, Arias B, Corcoran P, Fernández JM, Alvarez V, Coto E, Bascarán MT, Bousoño M, Fañanas L, Bobes J. Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb 01; 34(1):26-31. PubMed ID: 19766158 [Abstract] [Full Text] [Related]
11. DRD3 Ser9Gly polymorphism is related to thermal pain perception and modulation in chronic widespread pain patients and healthy controls. Potvin S, Larouche A, Normand E, de Souza JB, Gaumond I, Grignon S, Marchand S. J Pain; 2009 Sep 01; 10(9):969-75. PubMed ID: 19464960 [Abstract] [Full Text] [Related]
13. No allelic association or interaction of three known functional polymorphisms with bipolar disorder in a northern Swedish isolated population. Van Den Bogaert A, Sleegers K, De Zutter S, Heyrman L, Norrback KF, Adolfsson R, Van Broeckhoven C, Del-Favero J. Psychiatr Genet; 2006 Oct 01; 16(5):209-12. PubMed ID: 16969276 [Abstract] [Full Text] [Related]
16. Sensory gating deficit is associated with catechol-O-methyltransferase polymorphisms in bipolar disorder. Ancín I, Cabranes JA, Vázquez-Álvarez B, Santos JL, Sánchez-Morla E, García-Jiménez MÁ, Fernández C, Barabash A. World J Biol Psychiatry; 2011 Aug 01; 12(5):376-84. PubMed ID: 21595525 [Abstract] [Full Text] [Related]
17. Catechol-O-methyltransferase Val158Met polymorphism affects therapeutic response to mood stabilizer in symptomatic manic patients. Lee HY, Kim YK. Psychiatry Res; 2010 Jan 30; 175(1-2):63-6. PubMed ID: 20004480 [Abstract] [Full Text] [Related]
18. Schizotypy, attention deficit hyperactivity disorder, and dopamine genes. Ettinger U, Joober R, DE Guzman R, O'driscoll GA. Psychiatry Clin Neurosci; 2006 Dec 30; 60(6):764-7. PubMed ID: 17109713 [Abstract] [Full Text] [Related]
19. Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study. Massat I, Souery D, Del-Favero J, Nothen M, Blackwood D, Muir W, Kaneva R, Serretti A, Lorenzi C, Rietschel M, Milanova V, Papadimitriou GN, Dikeos D, Van Broekhoven C, Mendlewicz J. Mol Psychiatry; 2005 Jun 30; 10(6):598-605. PubMed ID: 15583702 [Abstract] [Full Text] [Related]